Burning Rock Biotech Limited
BNR
$8.83
-$0.46-4.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 72.50M | 72.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 72.50M | 72.50M |
| Cost of Revenue | -- | -- | -- | 20.67M | 20.67M |
| Gross Profit | -- | -- | -- | 51.83M | 51.83M |
| SG&A Expenses | -- | -- | -- | 52.53M | 52.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 101.84M | 101.84M |
| Operating Income | -- | -- | -- | -29.34M | -29.34M |
| Income Before Tax | -- | -- | -- | -32.25M | -32.25M |
| Income Tax Expenses | -- | -- | -- | 823.80K | 823.80K |
| Earnings from Continuing Operations | -- | -- | -- | -33.07 | -33.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -33.07M | -33.07M |
| EBIT | -- | -- | -- | -29.34M | -29.34M |
| EBITDA | -- | -- | -- | -16.66M | -16.66M |
| EPS Basic | -- | -- | -- | -32.04 | -32.04 |
| Normalized Basic EPS | -- | -- | -- | -0.75 | -0.75 |
| EPS Diluted | -- | -- | -- | -32.04 | -32.04 |
| Normalized Diluted EPS | -- | -- | -- | -0.75 | -0.75 |
| Average Basic Shares Outstanding | -- | -- | -- | 41.68M | 41.68M |
| Average Diluted Shares Outstanding | -- | -- | -- | 4.17M | 4.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |